1 |
Hindi NN, Alenbawi J, Nemer G. Pharmacogenomics Variability of Lipid-Lowering Therapies in Familial Hypercholesterolemia. J Pers Med 2021;11:877. [PMID: 34575654 DOI: 10.3390/jpm11090877] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
2 |
Wendt FR, Koller D, Pathak GA, Jacoby D, Miller EJ, Polimanti R. Biobank Scale Pharmacogenomics Informs the Genetic Underpinnings of Simvastatin Use. Clin Pharmacol Ther 2021;110:777-85. [PMID: 33837531 DOI: 10.1002/cpt.2260] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
3 |
Wells I, Ezzet S, Yamout N, Boutros M, Ray SD. Side effects of antilipid medications. Side Effects of Drugs Annual 2021. [DOI: 10.1016/bs.seda.2021.09.017] [Reference Citation Analysis]
|
4 |
Gabás‐rivera C, Jurado‐ruiz E, Sánchez‐ortiz A, Romanos E, Martínez‐beamonte R, Navarro MA, Surra JC, Arnal C, Rodríguez‐yoldi MJ, Andrés‐lacueva C, Osada J. Dietary Squalene Induces Cytochromes Cyp2b10 and Cyp2c55 Independently of Sex, Dose, and Diet in Several Mouse Models. Mol Nutr Food Res 2020;64:2000354. [DOI: 10.1002/mnfr.202000354] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
5 |
Montoya AM, Montesino CA, Carrión-Álvarez D, González GM, Rojas OC. A comparative study of extracellular enzymes from chromoblastomycosis agents reveals the potential association of phospholipase with the severity of the lesions. Microb Pathog 2020;147:104367. [PMID: 32649963 DOI: 10.1016/j.micpath.2020.104367] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|